Kaiser Health News
A federal official is defending new HHS interim rules against criticism that they favor insurers.
Experts say the success of the new pills hinge on whether high-risk patients will be able to get tested — and then treated — fast enough to make a difference.
Doctors and members of Congress are arguing that the rule for implementing the No Surprises Act favors insurers and doesn’t follow the spirit of the legislation.
PhRMA regards drug price negotiation for Medicare as an existential threat to its business — potentially costing billions.
Most parents are familiar with “COVID notification” letters, but the letters’ instruction on whether your kid must quarantine or not varies wildly from school to school.
Switching seniors to Medicare Advantage plans has cost taxpayers tens of billions of dollars more than keeping them in original Medicare.
They went into hospitals with heart attacks, kidney failure or in a psychiatric crisis, and they left with COVID-19 — if they left at all.
On key measures — prevention of serious illness, hospitalization and death — studies generally show COVID-19 vaccine protection weakening slightly, but remaining strong overall.
Over the past 20 years, hospitals and doctors have learned there’s great profit in upcoding visits.